Health Diaries > Got Bones?

September 17, 2006

Reclast - the Once a Year Bisphosphonate

Reclast, the latest osteoporosis drug that may be coming to market in 2007 will be a once-a-year treatment. Basically, you are given a massive "infusion" in one sitting. These drug companies keep trying to one-up each other. Boniva is trying to one-up Fosamax by putting out a once-a-month pill and now Novartis is going for once-a-year. What's next - once a lifetime? Let's go even further - how about never?

Why doesn't the Washington Post mention that it is a bisphosphonate and will carry the same risks as other bisphosphonates?

Reclast, given as an annual 15-minute infusion, reduced risk of new spine fractures by 70 percent and hip fractures by 40 percent, according to data supplied by the maker, Novartis Pharmaceuticals Corp. The drug, chemically known as zoledronic acid, also reduced the risk of fractures elsewhere, according to a just-completed international study of 7,736 postmenopausal women with osteoporosis.

Osteoporosis Drug Shown to Cut Fractures

Posted by Tracy on September 17, 2006 10:46 AM | DIGG | | furl

Post a comment

Remember Me?

(you may use HTML tags for style)


Got Bones?
is part of the
Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.


free get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.

Have a news tip or want to share your personal experience? Drop us a line at gotbones @ (remove the spaces).
All content published on is provided for informational and educational purposes only. does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2006-2007 and the authors. All rights reserved.